Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updates: added v3.4.2 and removed v3.4.1. These changes are minor and do not affect study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T00:34:36.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:48:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Introduced a glossary toggle and updated metadata labels, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision level updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T21:39:13.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A minor revision update was applied (from v3.3.3 to v3.3.4); no changes to study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:46:04.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added a centralized Locations section listing Arizona, California, Colorado, Georgia, New York, Pennsylvania, Tennessee, and Texas, and updated the revision to v3.3.3. Removed individual per-state location links and the HHS Vulnerability Disclosure.
    Difference
    0.9%
    Check dated 2025-12-23T21:06:47.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Publications section saw minor wording changes: new sentences clarify voluntary publication notes and auto-fill from PubMed, and the revision tag was updated to v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:23.000Z thumbnail image

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.